FDA | What's New
Follow
The Center for Drug Evaluation and Research's ARC Program Releases its 2026 Annual Report
The Accelerating Rare disease Cures (ARC) Program has released the 2026 Annual Report: Sustaining Progress, Expanding Possibilities in Rare Disease Drug Development.
